EDITORIAL COMMENT
Coronary arterial disease in patients undergoing percutaneous edge-to-edge mitral valve repair: Handle with care
First published: 14 April 2021
Expert Article Analysis for: Impact of preexisting coronary arterial disease in patients undergoing percutaneous mitral valve repair (MitraClip)
Key Points
- Percutaneous mitral valve repair using the MitraClip System is a revolutionary treatment option for patients with severe mitral regurgitation (MR) and prohibitive surgical risk.
- Coronary arterial disease is a frequent comorbidity in patients with severe MR.
- The impact of concomitant coronary artery disease and revascularization on outcome in patients undergoing transcatheter mitral valve repair is still an ongoing debate.
